Sort
39,280 grants matching “leukemia”
Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
$454,002A Koneti Rao · Temple Univ Of The Commonwealth · R01 · FY2021 · HL
Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
$454,002A Koneti Rao · Temple Univ Of The Commonwealth · R01 · FY2022 · HL
Steroid resistance of airway ILC2s
$453,987Rafeul Alam · National Jewish Health · R01 · FY2020 · AI
Defining and targeting asparaginase resistance mechanisms in high-risk acute leukemias
$453,934Alejandro Gutierrez · Boston Children'S Hospital · R01 · FY2020 · CA
Clinical treatment of advanced Merkel cell carcinoma
$453,913Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Developing and credentialing patient-derived xenograft models to advance therapeutic approaches for chronic myelomonocytic leukemia
$453,813Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2024 · CA
Molecular Inhibition of Apoptosis Inhibitors
$453,812John C Reed · University Of California, San Diego · P01 · FY2015 · CA
Structure and function in Notch Signaling
$453,803Stephen C. Blacklow · Harvard Medical School · R01 · FY2016 · CA
ETS1-dependent combinatorial control of oncogenic transcription in Notch-activated T-ALL
$453,685Mark Y Chiang · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Cancer Genomics and Epigenomics
$453,662Jean Gautier · Columbia University Health Sciences · P30 · FY2025 · CA
Pharmacological Blockage of XBP-1s Expression in Cancer
$453,625Juan R Del Valle · University Of South Florida · R01 · FY2017 · CA
Regulation of Hematopoiesis by Ribosomal Protein Paralogs
$453,613David L Wiest · Research Inst Of Fox Chase Can Ctr · R01 · FY2017 · AI
The function of cyclin C in tumorigenesis
$453,569Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2017 · CA
The function of cyclin C in tumorigenesis
$453,569Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2018 · CA
The function of cyclin C in tumorigenesis
$453,569Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2015 · CA
The function of cyclin C in tumorigenesis
$453,569Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Targeting Post-Transplant Minimal Residual CD19+ ALL with Genetically-
$453,508Laurence J.n. Cooper · Beckman Research Institute/City Of Hope · P01 · FY2007 · CA
Dissecting stress granule dependencies in leukemia stem cells
$453,466Eugene Wei-Ming Yeo · University Of California, San Diego · R01 · FY2025 · CA
Specific Adoptive Immunotherapy of Myeloid Malignancy
$453,406Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA
Hepatitis B virus integrations in KMT2B drive hepatocellular carcinoma
$453,403Jian Cao · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
Regulation of Hematopoiesis by Ribosomal Protein Paralogs
$453,377David L Wiest · Research Inst Of Fox Chase Can Ctr · R01 · FY2019 · AI
Health Promotion in Minority Childhood Cancer Survivors
$453,372Melinda R Stolley · University Of Illinois At Chicago · R01 · FY2009 · CA
Comparative Analysis of Genetic Interaction Networks
$453,371Trey Ideker · University Of California, San Diego · R01 · FY2017 · GM
Correlative Studies of erbB-2/HER2 and p53 in CALGB Pro.
$453,275University Of Michigan At Ann Arbor · R01 · FY2005 · CA
Project 1: Molecular Pathogenesis and Therapy of Myelofibrosis
$453,221Ross L Levine · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA